Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 4092-4102

  Kim, Oh Youn ^a   Hong, Bok Sil ^a   Park, Kyong Su ^a   Yoon, Yae Jin ^a   Choi, Seng Jin ^a   Lee, Won Hee ^a   Roh, Tae Young ^a   Lötvall, Jan ^b   Kim, Yoon Keun ^a   Gho, Yong Song ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI VACCINE; GAMMA INTERFERON; INTERLEUKIN 17;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL OUTER MEMBRANE; BACTERICIDAL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; EX VIVO STUDY; GRAM NEGATIVE SEPSIS; HUMORAL IMMUNITY; IMMUNIZATION; LETHALITY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TH1 CELL; TH17 CELL;

ADAPTIVE IMMUNITY; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI VACCINES; EXOSOMES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TH1 CELLS; TH17 CELLS;

EID: 84876001000     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200742     Document Type: Article

References (48)

1. Croxen, M. A., and B. B. Finlay. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8: 26-38.
2. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2: 123-140.
3. Levine, M. M., and M. B. Sztein. 2004. Vaccine development strategies for improving immunization: the role of modern immunology. Nat. Immunol. 5: 460-464.
4. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
5. Pepper, M., J. L. Linehan, A. J. Pagán, T. Zell, T. Dileepan, P. P. Cleary, and M. K. Jenkins. 2010. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11: 83-89.
6. Lin, L., A. S. Ibrahim, X. Xu, J. M. Farber, V. Avanesian, B. Baquir, Y. Fu, S. W. French, J. E. Edwards, Jr., and B. Spellberg. 2009. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 5: e1000703.
7. Nieves, W., S. Asakrah, O. Qazi, K. A. Brown, J. Kurtz, D. P. Aucoin, J. B. McLachlan, C. J. Roy, and L. A. Morici. 2011. A naturally derived outermembrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine 29: 8381-8389.
8. Moon, J. J., H. Suh, A. Bershteyn, M. T. Stephan, H. Liu, B. Huang, M. Sohail, S. Luo, S. H. Um, H. Khant, et al. 2011. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat. Mater. 10: 243-251.
9. Mashburn-Warren, L. M., and M. Whiteley. 2006. Special delivery: vesicle trafficking in prokaryotes. Mol. Microbiol. 61: 839-846.
10. Lee, E. Y., D. Y. Choi, D. K. Kim, J. W. Kim, J. O. Park, S. Kim, S. H. Kim, D. M. Desiderio, Y. K. Kim, K. P. Kim, and Y. S. Gho. 2009. Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics 9: 5425-5436.
11. Kuehn, M. J., and N. C. Kesty. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19: 2645-2655.
12. Wai, S. N., B. Lindmark, T. Söderblom, A. Takade, M. Westermark, J. Oscarsson, J. Jass, A. Richter-Dahlfors, Y. Mizunoe, and B. E. Uhlin. 2003. Vesicle-mediated export and assembly of pore-forming oligomers of the en-terobacterial ClyA cytotoxin. Cell 115: 25-35.
13. Lee, E. Y., D. S. Choi, K. P. Kim, and Y. S. Gho. 2008. Proteomics in gramnegative bacterial outer membrane vesicles. Mass Spectrom. Rev. 27: 535-555.
14. Horstman, A. L., and M. J. Kuehn. 2002. Bacterial surface association of heat-labile enterotoxin through lipopolysaccharide after secretion via the general secretory pathway. J. Biol. Chem. 277: 32538-32545.
15. Alaniz, R. C., B. L. Deatherage, J. C. Lara, and B. T. Cookson. 2007. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol. 179: 7692-7701.
16. Park, K. S., K. H. Choi, Y. S. Kim, B. S. Hong, O. Y. Kim, J. H. Kim, C. M. Yoon, G. Y. Koh, Y. K. Kim, and Y. S. Gho. 2010. Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS ONE 5: e11334.
17. Dalseg, R., E. Wedege, J. Holst, I. L. Haugen, E. A. Høiby, and B. Haneberg. 1999. Outer membrane vesicles from group B meningococci are strongly im-munogenic when given intranasally to mice. Vaccine 17: 2336-2345.
18. Haneberg, B., R. Dalseg, E. Wedege, E. A. Høiby, I. L. Haugen, F. Oftung, S. R. Andersen, L. M. Naess, A. Aase, T. E. Michaelsen, and J. Holst. 1998. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect. Immun. 66: 1334-1341.
19. Keenan, J., T. Day, S. Neal, B. Cook, G. Perez-Perez, R. Allardyce, and P. Bagshaw. 2000. A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol. Lett. 182: 259-264.
20. Kesavalu, L., J. L. Ebersole, R. L. Machen, and S. C. Holt. 1992. Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect. Immun. 60: 1455-1464.
21. Masignani, V., M. Comanducci, M. M. Giuliani, S. Bambini, J. Adu-Bobie, B. Arico, B. Brunelli, A. Pieri, L. Santini, S. Savino, et al. 2003. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J. Exp. Med. 197: 789-799.
22. McConnell, M. J., C. Rumbo, G. Bou, and J. Pachón. 2011. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 29: 5705-5710.
23. Saunders, N. B., D. R. Shoemaker, B. L. Brandt, E. E. Moran, T. Larsen, and W. D. Zollinger. 1999. Immunogenicity of intranasally administered meningo-coccal native outer membrane vesicles in mice. Infect. Immun. 67: 113-119.
24. Schild, S., E. J. Nelson, A. L. Bishop, and A. Camilli. 2009. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect. Immun. 77: 472-484.
25. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
26. Hotchkiss, R. S., K. C. Chang, M. H. Grayson, K. W. Tinsley, B. S. Dunne, C. G. Davis, D. F. Osborne, and I. E. Karl. 2003. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl. Acad. Sci. USA 100: 6724-6729.
27. Amano, A., H. Takeuchi, and N. Furuta. 2010. Outer membrane vesicles function as offensive weapons in host-parasite interactions. Microbes Infect. 12: 791-798.
28. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10: 170-181.
29. Priebe, G. P., R. L. Walsh, T. A. Cederroth, A. Kamei, Y. S. Coutinho-Sledge, J. B. Goldberg, and G. B. Pier. 2008. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. J. Immunol. 181: 4965-4975.
30. Spellberg, B., A. S. Ibrahim, L. Lin, V. Avanesian, Y. Fu, P. Lipke, H. Otoo, T. Ho, and J. E. Edwards, Jr. 2008. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J. Infect. Dis. 197: 967-971.
31. Collins, B. S. 2011. Gram-negative outer membrane vesicles in vaccine development. Discov. Med. 12: 7-15.
32. Borrow, R., P. Balmer, and E. Miller. 2005. Meningococcal surrogates of protection-serum bactericidal antibody activity. Vaccine 23: 2222-2227.
33. Holst, J., D. Martin, R. Arnold, C. C. Huergo, P. Oster, J. O'Hallahan, and E. Rosenqvist. 2009. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27(Suppl 2): B3-B12.
34. van de Waterbeemd, B., M. Streefland, P. van der Ley, B. Zomer, H. van Dijken, D. Martens, R. Wijffels, and L. van der Pol. 2010. Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine 28: 4810-4816.
35. Wilson, C. B., and E. K. Marcuse. 2001. Vaccine safety-vaccine benefits: science and the public's perception. Nat. Rev. Immunol. 1: 160-165.
36. Chen, D. J., N. Osterrieder, S. M. Metzger, E. Buckles, A. M. Doody, M. P. DeLisa, and D. Putnam. 2010. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc. Natl. Acad. Sci. USA 107: 3099-3104.
37. Granoff, D. M. 2010. Review of meningococcal group B vaccines. Clin. Infect. Dis. 50(Suppl 2): S54-S65.
38. Guthrie, T., S. Y. Wong, B. Liang, L. Hyland, S. Hou, E. A. Høiby, and S. R. Andersen. 2004. Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis. Infect. Immun. 72: 2528-2537.
39. Ferrari, G., I. Garaguso, J. Adu-Bobie, F. Doro, A. R. Taddei, A. Biolchi, B. Brunelli, M. M. Giuliani, M. Pizza, N. Norais, and G. Grandi. 2006. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 6: 1856-1866.
40. Eisenstein, T. K. 1999. Mucosal immune defense: the Salmonella typhimurium model. Bacterial Vaccine Vectors. Wiley-Liss, New York, p. 51-109
41. Mittrücker, H. W., B. Raupach, A. Köhler, and S. H. Kaufmann. 2000. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J. Immunol. 164: 1648-1652.
42. Bai, H., J. Cheng, X. Gao, A. G. Joyee, Y. Fan, S. Wang, L. Jiao, Z. Yao, and X. Yang. 2009. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J. Immunol. 183: 5886-5895.
43. Allam, U. S., M. G. Krishna, A. Lahiri, O. Joy, and D. Chakravortty. 2011. Salmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid. PLoS ONE 6: e16667.
44. Curtis, M. M., and S. S. Way. 2009. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126: 177-185.
45. Higgins, S. C., A. G. Jarnicki, E. C. Lavelle, and K. H. G. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177: 7980-7989.
46. Lin, Y., S. Ritchea, A. Logar, S. Slight, M. Messmer, J. Rangel-Moreno, L. Guglani, J. F. Alcorn, H. Strawbridge, S. M. Park, et al. 2009. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31: 799-810.
47. Hong, S. W., M. R. Kim, E. Y. Lee, J. H. Kim, Y. S. Kim, S. G. Jeon, J. M. Yang, B. J. Lee, B. Y. Pyun, Y. S. Gho, and Y. K. Kim. 2011. Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation. Allergy 66: 351-359.
48. Rivera, J., R. J. Cordero, A. S. Nakouzi, S. Frases, A. Nicola, and A. Casadevall. 2010. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc. Natl. Acad. Sci. USA 107: 19002-19007.